BOHRF Original Authors' Main Conclusions
The original authors' main conclusions are taken from Abstract, Results and
Discussion. They are decided upon by the authors of the BOHRF occupational
asthma guidelines and form part of the guidelines.
The audit tool, against which clinical activity should be measured, is revised as follows. All
patients with suspected OA should, as a minimum, have the following clearly documented in
their health records.
By first visit
o Presence or absence of asthma prior to potentially harmful asthmagen exposure at work
o Presence or absence of work-related eye or nasal symptoms
o Presence or absence of work-related respiratory symptoms and their duration
o A full list of occupations held, their durations, and likely associated occupational exposures
o Current ongoing asthmagen exposure
o Whether other workers at the same workplace are affected
o FEV1, FVC, and the degree of airflow limitation, compared to predicted values
By second visit
o If at work and appropriate; serial PEF measurements taken for at least 3 continuous weeks including rest days, with at least 4 good quality readings per day, analysed to assess work relatedness.
o If performed, the results of non specific bronchial responsiveness
o If exposed to allergen with appropriate specific IgE measure or skin prick test, the result of this test.
BOHRF Associated Evidence Statements
The BOHRF occupational asthma guidelines state that this reference is associated
with the following evidence statements
This page is showing the information from the BOHRF occupational asthma guidelines for this reference. To see additional information, including opinions left by users of this website please view the full reference. This page allows users to comment on the reference and suggest it as evidence for questions. These may be the existing questions from the Bohrf occupational asthma guidelines or questions that have been put forward by users of this website.